Home

Symptoms

Read time: 3 min

Satellite symposium

The COVID-19 pandemic and mental health - impact and implications

One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the...

Read time: 3 min

Satellite symposium

Thinking clearly with schizophrenia

The impact of cognitive impairment associated with schizophrenia (CIAS) is wide reaching, affecting...

Read time: 3 min

Satellite symposium

Potential treatment options for trauma-associated depression and emotional blunting

Mass traumatic events, such as the global COVID-19 pandemic, significantly impact on mental health...

Read time: 3 min

Satellite symposium

Exploring the interplay between COVID-19 and major depressive disorder

The COVID-19 pandemic represents a ‘triple threat’, impacting not only the physical...

Read time: 5 min

Congress highlights

Recovery – from schizophrenia symptoms to well-being

Recovery in an important focus in the treatment and management of schizophrenia but what exactly is...

Read time: 4 min

Congress highlights

Moving towards achieving full functional recovery in depression and getting back to pre-depression lifestyle

Addressing the cognitive symptoms of depression that affect attention, memory, executive function...

Read time: 3 min

Congress highlights

Finding the sweet spot for pharmacotherapy in schizophrenia

Over recent years, the goals in the management of patients with schizophrenia have evolved from...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country